South Korea has unveiled a set of regulatory innovation measures designed to foster the biopharma industry, particularly new vaccines and technologies, by boosting investment, speeding up processes, aligning with global standards and adopting systems appropriate for the latest technologies.
As part of the measures, a planned government mega fund to support the sector is taking more concrete shape, with the initial formation of a large-scale vaccine fund due this year to support the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?